NeurAxis, Inc. (NRXS) 은(는) 상장 기업입니다 헬스케어 섹터의 바이오 산업에서 운영. 본사 소재지는 Carmel, IN, 미국. 현재 CEO는 Brian Carrico.
NRXS 을(를) 보유 IPO 날짜 2023-08-09, 21 명의 정규직 직원, 에 상장 American Stock Excha, 시가총액 $78.31M.
NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome healthcare companies primarily hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.
